24 million Americans prioritize Covid-19 vaccination 4
The two groups include 24 million of America’s 330 million citizens.
From mid to late this month, the US Food and Drug Administration (FDA) will consider approving the emergency use of two vaccines, produced by Pfizer and Moderna.
The Advisory Committee on Immunization Practices will meet as soon as possible to decide on the next group to receive the vaccine.
The Commission’s December 1 move was simply to specify who needs to be vaccinated first.
Volunteers are injected with a Covid-19 vaccine trial in Harpersville, New York, July 2020.
Experts say the vaccine will likely not be widely distributed in the US until spring 2021. The approval process is often complex and time-consuming.
The Advisory Committee’s opinions are not binding.
Also during the meeting, Dr. Beth Bell, University of Washington, noted that on average every minute, an American dies from Covid-19.
Still, some Advisory Committee members said they felt hesitant to include these people in the priority group.
`I think it’s too early to put the elderly in nursing homes in the priority group. Advocates seem to think they will respond well to the vaccine, but this is not certain,` Talbot said.
